RxDoctor Payments Data

Nadezhda Davis

Nurse Practitioner · Lynwood, CANPI 1033269188

Payments from drug & device makers

$8,381in general payments, 2019–2025

Across 356 payments — averaging $23.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$2K
  • Johnson & Johnson$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Alkermes, Inc.$1K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$470
  • plus $1K from 7 others

What the payments were for

  • Food & beverage$8,12197%
  • Education$2603%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,381 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate17$128,160
CaplytaLumateperone Tosylate45$73,619
Abilify MaintenaAripiprazole15$40,559
Invega SustennaPaliperidone Palmitate13$36,509
VivitrolNaltrexone Microspheres12$18,588
Lurasidone Hcl24$3,145
Olanzapine14$465
Aripiprazole15$434
Quetiapine Fumarate ErQuetiapine Fumarate12$288
Divalproex Sodium11$240
Trazodone Hcl35$237
Sertraline Hcl13$153
Risperidone26$128
Mirtazapine12$124
Divalproex Sodium ErDivalproex Sodium11$80

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$1,506$128,16017 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,350$73,61945 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$470$40,55915 claims
Johnson & JohnsonInvega Sustenna$1,474$36,50913 claims
Alkermes, Inc.Vivitrol$1,080$18,58812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Lynwood

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →